I agree that this site is using cookies. You can find further informations here.
X
Nakagawa, Hidemi
428  results:
Search for persons X
?
1

Safety, efficacy, and pharmacokinetics of delgocitinib oint..:

Nakagawa, Hidemi ; Igarashi, Atsuyuki ; Saeki, Hidehisa...
Allergology International.  73 (2024)  1 - p. 137-142 , 2024
Link: https://doi.org/10.1016/..
 
?
2

High prevalence of dermatophytosis of the feet in acral mel..:

Waki, Yuma ; Nobeyama, Yoshimasa ; Nakagawa, Hidemi.
The Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
3

Bimekizumab Efficacy and Safety in Japanese Patients with P..:

Asahina, Akihiko ; Okubo, Yukari ; Morita, Akimichi...
Dermatology and Therapy.  13 (2023)  3 - p. 751-768 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Efficacy and Safety of Certolizumab Pegol in Japanese Patie..:

Okubo, Yukari ; Umezawa, Yoshinori ; Sakurai, Shinya..
Dermatology and Therapy.  12 (2022)  6 - p. 1397-1415 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Generation of induced pluripotent stem cell (iPSC) from NY‐..:

Itoh, Munenari ; Kawagoe, Shiho ; Nakagawa, Hidemi..
Experimental Dermatology.  32 (2022)  2 - p. 126-134 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Efficacy and safety of tildrakizumab in Japanese patients w..:

Igarashi, Atsuyuki ; Nakagawa, Hidemi ; Morita, Akimichi...
The Journal of Dermatology.  48 (2021)  6 - p. 853-863 , 2021
Link: https://doi.org/10.1111/..
 
?
7

Characteristics of anti-IL-17/23 biologics-induced intersti..:

Miyagawa, Hanae ; Hara, Hiromichi ; Araya, Jun...
PLOS ONE.  16 (2021)  1 - p. e0245284 , 2021
Link: https://doi.org/10.1371/..
 
?
8

Delgocitinib ointment in pediatric patients with atopic der..:

Nakagawa, Hidemi ; Nemoto, Osamu ; Igarashi, Atsuyuki...
Journal of the American Academy of Dermatology.  85 (2021)  4 - p. 854-862 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Effect of anti‐interleukin‐17 biologics on Krebs von den Lu..:

Hara, Hiromichi ; Miyagawa, Hanae ; Araya, Jun...
The Journal of Dermatology.  48 (2021)  6 - p. 886-893 , 2021
Link: https://doi.org/10.1111/..
 
?
10

Efficacy and Safety of Certolizumab Pegol in Japanese Patie..:

Umezawa, Yoshinori ; Asahina, Akihiko ; Imafuku, Shinichi...
Dermatology and Therapy.  11 (2021)  3 - p. 943-960 , 2021
Link: https://doi.org/10.1007/..
 
?
11

25094 Delgocitinib ointment in pediatric patients with atop..:

Nakagawa, Hidemi ; Nemoto, Osamu ; Igarashi, Atsuyuki...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB52 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Long‐term efficacy and safety of tildrakizumab in Japanese ..:

Imafuku, Shinichi ; Nakagawa, Hidemi ; Igarashi, Atsuyuki...
The Journal of Dermatology.  48 (2021)  6 - p. 844-852 , 2021
Link: https://doi.org/10.1111/..
 
?
13

Certolizumab Pegol for the Treatment of Moderate to Severe ..:

Umezawa, Yoshinori ; Sakurai, Shinya ; Hoshii, Naoki..
Dermatology and Therapy.  11 (2021)  2 - p. 513-528 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Certolizumab Pegol in Japanese Patients with Moderate to Se..:

Imafuku, Shinichi ; Tada, Yayoi ; Umezawa, Yoshinori...
Dermatology and Therapy.  12 (2021)  1 - p. 121-135 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Associations of TNFAIP3 variants with susceptibility to pso..:

Momose, Mami ; Hirota, Tomomitsu ; Kikuchi, Sota...
Journal of Dermatological Science.  100 (2020)  3 - p. 220-222 , 2020
Link: https://doi.org/10.1016/..
 
1-15